$151 Million is the total value of Opus Point Partners Management, LLC's 57 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 55.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IBB | Buy | ISHARES TRnasdq biotec etf | $10,691,000 | +76.2% | 31,600 | +58.0% | 7.06% | +110.8% |
| ALKS | Buy | ALKERMES PLC | $6,939,000 | +36.2% | 87,415 | +0.6% | 4.58% | +62.9% |
| IONS | New | IONIS PHARMACEUTICALS INC | $6,345,000 | – | 102,459 | +100.0% | 4.19% | – |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $6,289,000 | +21.8% | 32,969 | -0.2% | 4.16% | +45.7% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $5,874,000 | +20.6% | 348,583 | -21.5% | 3.88% | +44.4% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $5,816,000 | +17.7% | 10,714 | +0.8% | 3.84% | +40.8% |
| AMGN | Buy | AMGEN INC | $5,807,000 | +646.4% | 35,773 | +535.9% | 3.84% | +792.1% |
| CELG | Buy | CELGENE CORP | $5,743,000 | +12.6% | 47,956 | +1.7% | 3.79% | +34.8% |
| SGEN | Buy | SEATTLE GENETICS INC | $5,704,000 | +18.8% | 127,088 | +2.0% | 3.77% | +42.1% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $5,304,000 | +148.9% | 77,100 | +114.2% | 3.50% | +197.7% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $5,242,000 | +23.1% | 41,662 | +1.9% | 3.46% | +47.3% |
| INCY | Buy | INCYTE CORP | $5,210,000 | -0.4% | 48,045 | +1.4% | 3.44% | +19.2% |
| MRK | Buy | MERCK & CO INC NEW | $4,754,000 | +134.8% | 90,000 | +119.5% | 3.14% | +180.9% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $4,728,000 | +21.4% | 50,222 | +3.7% | 3.12% | +45.3% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $4,596,000 | +3.9% | 43,870 | +4.4% | 3.04% | +24.3% |
| QGEN | QIAGEN NV | $4,424,000 | +7.2% | 160,000 | 0.0% | 2.92% | +28.3% | |
| MDVN | Sell | MEDIVATION INC | $4,414,000 | -12.3% | 91,310 | -22.9% | 2.92% | +5.0% |
| ILMN | Sell | ILLUMINA INC | $4,346,000 | -12.8% | 22,643 | -20.1% | 2.87% | +4.4% |
| GILD | Buy | GILEAD SCIENCES INC | $3,410,000 | +704.2% | 33,700 | +679.6% | 2.25% | +862.8% |
| MTD | Sell | METTLER TOLEDO INTERNATIONAL | $3,290,000 | -24.0% | 9,700 | -36.2% | 2.17% | -9.1% |
| BIIB | Sell | BIOGEN INC | $3,211,000 | -37.0% | 10,482 | -40.0% | 2.12% | -24.6% |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $2,266,000 | – | 80,000 | +100.0% | 1.50% | – |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $2,207,000 | -32.0% | 34,000 | -26.1% | 1.46% | -18.7% |
| EPZM | Buy | EPIZYME INC | $2,173,000 | +266.4% | 135,627 | +194.3% | 1.44% | +339.1% |
| HOLX | HOLOGIC INC | $1,857,000 | -1.1% | 48,000 | 0.0% | 1.23% | +18.3% | |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $1,750,000 | -67.5% | 50,000 | -14.6% | 1.16% | -61.1% |
| LOXO | New | LOXO ONCOLOGY INC | $1,707,000 | – | 60,000 | +100.0% | 1.13% | – |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $1,667,000 | -61.5% | 49,100 | -63.9% | 1.10% | -53.9% |
| NSTG | NANOSTRING TECHNOLOGIES INC | $1,503,000 | -8.1% | 102,200 | 0.0% | 0.99% | +10.0% | |
| PCRX | Sell | PACIRA PHARMACEUTICALS INC | $1,467,000 | +70.0% | 19,110 | -9.0% | 0.97% | +103.1% |
| ZGNX | Buy | ZOGENIX INC | $1,411,000 | +59.1% | 95,700 | +45.7% | 0.93% | +90.2% |
| RXDX | New | IGNYTA INC | $1,340,000 | – | 100,000 | +100.0% | 0.88% | – |
| OPHT | Buy | OPHTHOTECH CORP | $1,335,000 | +360.3% | 17,000 | +137.8% | 0.88% | +451.2% |
| XNCR | New | XENCOR INC | $1,316,000 | – | 90,000 | +100.0% | 0.87% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $1,187,000 | – | 100,000 | +100.0% | 0.78% | – |
| MCRB | New | SERES THERAPEUTICS INC | $1,158,000 | – | 33,000 | +100.0% | 0.76% | – |
| PRTK | New | PARATEK PHARMACEUTICALS INC | $1,138,000 | – | 60,000 | +100.0% | 0.75% | – |
| ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $1,079,000 | +47.2% | 100,000 | -5.8% | 0.71% | +76.0% |
| BIB | Sell | PROSHARES TR | $1,067,000 | -44.0% | 14,919 | -54.4% | 0.70% | -33.0% |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $1,032,000 | – | 100,000 | +100.0% | 0.68% | – |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $1,020,000 | +39.5% | 6,514 | +16.9% | 0.67% | +66.8% |
| MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $968,000 | +83.3% | 122,500 | +97.6% | 0.64% | +118.8% |
| MDCO | New | MEDICINES CO | $934,000 | – | 25,000 | +100.0% | 0.62% | – |
| MGNX | New | MACROGENICS INC | $929,000 | – | 30,000 | +100.0% | 0.61% | – |
| VCEL | VERICEL CORP | $857,000 | -4.8% | 332,157 | 0.0% | 0.57% | +13.9% | |
| NVAX | NOVAVAX INCput | $839,000 | +18.7% | 100,000 | 0.0% | 0.55% | +42.1% | |
| NVAX | NOVAVAX INCcall | $839,000 | +18.7% | 100,000 | 0.0% | 0.55% | +42.1% | |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $795,000 | +412.9% | 60,000 | +306.8% | 0.52% | +510.5% |
| FLDM | Buy | FLUIDIGM CORP DEL | $757,000 | +520.5% | 70,000 | +366.7% | 0.50% | +646.3% |
| FLML | FLAMEL TECHNOLOGIES SAsponsored adr | $693,000 | -25.2% | 56,788 | 0.0% | 0.46% | -10.4% | |
| TKAI | New | TOKAI PHARMACEUTICALS INC | $541,000 | – | 62,007 | +100.0% | 0.36% | – |
| DNAI | New | PRONAI THERAPEUTICS INC | $451,000 | – | 30,000 | +100.0% | 0.30% | – |
| AXGT | Sell | AXOVANT SCIENCES LTD | $340,000 | -14.4% | 18,852 | -38.6% | 0.22% | +2.7% |
| DPRX | New | DIPEXIUM PHARMACEUTICALS INC | $280,000 | – | 25,000 | +100.0% | 0.18% | – |
| INFI | Sell | INFINITY PHARMACEUTICALS INC | $236,000 | -38.4% | 30,000 | -33.8% | 0.16% | -26.1% |
| CBYL | New | CARBYLAN THERAPEUTICS INC | $63,000 | – | 17,500 | +100.0% | 0.04% | – |
| RPRXZ | New | REPROS THERAPEUTICS INCcall | $33,000 | – | 98,000 | +100.0% | 0.02% | – |
| XNPT | Exit | XENOPORT INC | $0 | – | -40,000 | -100.0% | -0.08% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -15,000 | -100.0% | -0.08% | – |
| ACRX | Exit | ACELRX PHARMACEUTICALS INC | $0 | – | -57,747 | -100.0% | -0.10% | – |
| LABU | Exit | DIREXION SHS ETF TR | $0 | – | -14,850 | -100.0% | -0.13% | – |
| NHLD | Exit | NATIONAL HOLDINGS CORP | $0 | – | -89,530 | -100.0% | -0.14% | – |
| ARWR | Exit | ARROWHEAD RESH CORP | $0 | – | -51,133 | -100.0% | -0.16% | – |
| RPRX | Exit | REPROS THERAPEUTICS INCcall | $0 | – | -98,000 | -100.0% | -0.27% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -14,152 | -100.0% | -0.30% | – |
| STML | Exit | STEMLINE THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -0.37% | – |
| CRIS | Exit | CURIS INC | $0 | – | -374,500 | -100.0% | -0.42% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -250,000 | -100.0% | -0.63% | – |
| CPHD | Exit | CEPHEID | $0 | – | -90,000 | -100.0% | -2.25% | – |
| ISIS | Exit | ISIS PHARMACEUTICALS INC | $0 | – | -101,401 | -100.0% | -2.26% | – |
| TECH | Exit | BIO TECHNE CORP | $0 | – | -47,000 | -100.0% | -2.40% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -862,500 | -100.0% | -29.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| METTLER-TOLEDO INTL CMN | 20 | Q3 2019 | 4.7% |
| ALNYLAM PHARMACEUTICALS, INC. CMN | 20 | Q3 2019 | 5.0% |
| VERTEX PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.0% |
| ILLUMINA, INC. CMN | 20 | Q3 2019 | 4.4% |
| SEATTLE GENETICS, INC. CMN | 20 | Q3 2019 | 4.0% |
| ALEXION PHARMACEUTICALS INC CMN | 20 | Q3 2019 | 4.3% |
| INCYTE CORPORATION CMN | 20 | Q3 2019 | 4.4% |
| NEKTAR THERAPEUTICS CMN | 20 | Q3 2019 | 4.9% |
| REGENERON PHARMACEUTICALS | 20 | Q3 2019 | 3.8% |
| CELGENE CORPORATION CMN | 20 | Q3 2019 | 3.8% |
View Opus Point Partners Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-17 |
| 13F-HR | 2017-11-14 |
View Opus Point Partners Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.